首页> Frontiers in pharmacology> Enzymatic post-translational modifications of proteins in chronic kidney disease: mechanisms, regulation, and clinical significance.

Enzymatic post-translational modifications of proteins in chronic kidney disease: mechanisms, regulation, and clinical significance.

导出 LinkOut

翻译打印收藏纠错

第一作者： Minlong,Wei

第一单位： Key Laboratory of Drug Metabolism Research and Evaluation of the State Drug Administration, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.

作者： Minlong,Wei ^[1] ; Jinyun,Lin ^[1] ; Yi,Zeng ^[2] ; Xiaojuan,Wang ^[2] ; Jialu,Wen ^[1] ; Jing,Wang ^[3] ; Wei,Zou ^[4] ; Kang,Tu ^[1] ; Menghua,Liu ^[1] ; Juan,Li ^[5]

作者单位： Key Laboratory of Drug Metabolism Research and Evaluation of the State Drug Administration, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China. ^[1] Southern Medical University Hospital of Integrated Traditional Chinese and Western Medicine, Southern Medicine University, Guangzhou, China. ^[2] School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China. ^[3] Changsha Research and Development Center on Obstetric and Gynecologic Traditional Chinese Medicine Preparation, Hunan Provincial Maternal and Child Healthcare Hospital, Changsha, Hunan, China. ^[4] School of Nursing, Southern Medical University, Guangzhou, Guangdong, China. ^[5]

关键词 acetylation chronic kidney disease enzymatic post-translational modifications lactylation methylation therapeutictargets

DOI 10.3389/fphar.2025.1678812

PMID 41132539

发布时间 2025-10-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交